![Ingmar Bruns](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 94 068 $ in data 31/08/2026
Ingmar Bruns is currently the Chief Medical Officer at Zentalis Pharmaceuticals, Inc. He previously held the position of Chief Medical Officer at Trillium Therapeutics, Inc. from 2020 to 2021.
He also worked as the Senior Vice President-Clinical Development at Pieris Pharmaceuticals, Inc. Dr. Bruns obtained a doctorate degree from Universität zu Lübeck.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 20/04/2026 | 25.018 ( 0,03% ) | 94 068 $ | 31/08/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| ZENTALIS PHARMACEUTICALS, INC. | Direttore Tecnico/Scientifico/R&S | 13/11/2024 |
| Società | Posizione | Fine |
|---|---|---|
| TRILLIUM THERAPEUTICS | Direttore Tecnico/Scientifico/R&S | 17/11/2021 |
| PIERIS PHARMACEUTICALS | Corporate Officer/Principal | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 4 |
|---|---|
Trillium Therapeutics, Inc.
 Trillium Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Researches, develops and manufactures medicines & therapies for cancer | Health Technology |
Universität zu Lübeck
 Universität zu Lübeck Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pieris Pharmaceuticals, Inc.
 Pieris Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops and markets an anticalin-brand protein technology | Health Technology |
Zentalis Pharmaceuticals, Inc.
 Zentalis Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops clinical therapeutics for targeting fundamental cancer pathways | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
